News & Media

Take a closer look at what we’re doing across Teva worldwide

Top Stories

Read the latest Teva news.

Life changing Migraine Treatment to be listed on PBS

Life changing Migraine Treatment to be listed on PBS

New PBS listing of AJOVY® to address significant unmet need in adults with chronic migraine

New PBS listing of AJOVY® to address significant unmet need in adults with chronic migraine

Our ESG Progress: Four Employee Perspectives

Our ESG Progress: Four Employee Perspectives

Coronavirus (COVID-19) Teva Australia

Coronavirus (COVID-19) Teva Australia

New preventive treatment for migraine now licensed in Australia

New preventive treatment for migraine now licensed in Australia

Teva Australia Launches new Brand

Teva Australia Launches new Brand

Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility

Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility

Media Inquiries

Contact Teva Corporate Communications.

Learn more Media Inquiries

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Contact us

You can contact us at any time with your questions or remarks.

Read more Contact us